Latest filing published 05 Mar 2026 for LeonaBio, Inc..
This profile gathers the share dealings of Robert Renninger in LeonaBio, Inc. Between 18 November 2024 and 4 March 2026, the trades on record add up to 11 filings.
No open-market purchase appears, only 4 sales worth €8,213. Other entries cover 3 share grants and 4 option exercises. Since January 2026: no purchases and 2 sales on the market.
The latest filing, published on 5 March 2026, reports an open-market sale of €4,190 in LeonaBio, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations